Lido Advisors »

Corvus Pharmaceuticals shares owned by Lido Advisors

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Lido Advisors from 13F filings

Historical chart of Lido Advisors investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Lido Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Lido Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $243k 16k 14.94

More positions owned by Lido Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple Put Option (AAPL)
NVIDIA Corporation Put Option (NVDA)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ssga Active Tr State Street My (MYCH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Broadcom Put Option (AVGO)

View all positions for Lido Advisors

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Adams Street Partners
T. Rowe Price Associates
Vivo Capital
Wellington Management Company
Perceptive Advisors
Morgan Stanley
Deep Track Capital
Braidwell
Geode Capital Management
Foresite Capital Management VI
Goldman Sachs Group

View all funds holding Corvus Pharmaceuticals